The purpose of the present invention is to provide an (anti-CDH3 antibody)-drug conjugate which can highly efficiently kill a cancer cell capable of expressing CDH3. The present invention provides an immunological complex produced by linking an antibody against CDH3 or a fragment thereof that is capable of binding to CDH3 to a chemotherapeutic agent.